Resultats de la cerca - Wu‐Chou Su
- Mostrar 1 - 20 resultats de 72
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Sp1 expression regulates lung tumor progression per Tsung‐I Hsu, M-C Wang, S. Y. Chen, Y-M Yeh, Wu‐Chou Su, W-C Chang, Jan‐Jong Hung
Publicat 2011Artigo -
10
Pronounced induction of endoplasmic reticulum stress and tumor suppression by surfactant-free poly (lactic-co-glycolic acid) nanoparticles via modulation of the PI3K signaling path... per Chia Cheng Hou, Tsung‐Lin Tsai, Wen Pin Su, Hsing Pang Hsieh, Chen-Sheng Yeh, Dar Bin Shieh, Wu‐Chou Su
Publicat 2013Artigo -
11
Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and... per Wei-Lun Huang, Hsuan-Heng Yeh, Chien‐Chung Lin, Wu‐Wei Lai, Jang-Yang Chang, Wen-Tsan Chang, Wu‐Chou Su
Publicat 2010Artigo -
12
-
13
-
14
-
15
Psychometric evaluation of the WHOQOL-BREF, Taiwan version, across five kinds of Taiwanese cancer survivors: Rasch analysis and confirmatory factor analysis per Chung‐Ying Lin, Jing-Shiang Hwang, Wen‐Chung Wang, Wu‐Wei Lai, Wu‐Chou Su, Tzu‐Yi Wu, Grace Yao, Jung‐Der Wang
Publicat 2018Artigo -
16
Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy per Helen H.W. Chen, Jiang Yan, Wen-Chung Chen, Macus Tien Kuo, Yu-Hsuan Lai, Wu Wei Lai, Hsiao‐Sheng Liu, Wu‐Chou Su
Publicat 2011Artigo -
17
IL-33/NF-κB/ST2L/Rab37 positive-feedback loop promotes M2 macrophage to limit chemotherapeutic efficacy in lung cancer per You-En Yang, Meng-Hsuan Hu, Yen-Chen Zeng, Yau‐Lin Tseng, Ying-Yung Chen, Wu‐Chou Su, Chih‐Peng Chang, Yi‐Ching Wang
Publicat 2024Artigo -
18
Global Oct4 target gene analysis reveals novel downstream <i>PTEN</i> and <i>TNC</i> genes required for drug-resistance and metastasis in lung cancer per Yen-An Tang, Chi-Hsin Chen, H. Sunny Sun, Chun-Pei Cheng, Vincent S. Tseng, Han‐Shui Hsu, Wu‐Chou Su, Wu‐Wei Lai, Yi‐Ching Wang
Publicat 2015Artigo -
19
A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer per Andrew H. Ko, Margaret A. Tempero, Y-S Shan, Wu‐Chou Su, Yulin Lin, Elizabeth Dito, A. Ong, Y-W Wang, Chen‐Hao Yeh, L-T. Chen
Publicat 2013Artigo -
20
Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer per Po‐Lan Su, Yi‐Lin Wu, Wei-Yuan Chang, Chung‐Liang Ho, Yau‐Lin Tseng, Wu‐Wei Lai, Wu‐Chou Su, Chien‐Chung Lin, Szu‐Chun Yang
Publicat 2018Artigo
Eines de cerca:
Matèries relacionades
Medicine
Internal medicine
Cancer
Oncology
Biology
Lung cancer
Genetics
Cancer research
Gene
Epidermal growth factor receptor
Gastroenterology
Adverse effect
Biochemistry
Cell biology
Chemotherapy
Gefitinib
Adenocarcinoma
Clinical endpoint
Clinical trial
Erlotinib
Pathology
Confidence interval
Phases of clinical research
Tyrosine-kinase inhibitor
Surgery
Environmental health
Genotype
Metastasis
Receptor
Response Evaluation Criteria in Solid Tumors